Mission Therapeutics

Developer of small molecule inhibitors targeting specific disease associated enzymes

placeCambridge, England, United Kingdom calendar_todayFounded 2011 groups45 employees language missiontherapeutics.com

Registered entities

Innovation

33 patent families (22 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace slowing. Cited 2,148 times.

YearFilings
20152
20163
201713
201818
201915
202018
202121
202218
20239
202411
20256
20262

Social engagement

Social engagement: 9.1K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

48 investors on record; lead investors include Imperial Innovations, Woodford Investment Management, Roche, Pfizer Venture Investments.

Investor typeCountShare
Venture capital613%
Private equity12%
Accelerator & incubator12%
Bank & private debt12%
Other / undisclosed3981%

Recent activity

17 Feb 2026
Recognition
Coming soon